PubMed

Alzheimer's disease therapeutic research: the path forward.

Aisen PS.

Alzheimers Res Ther. 2009 Jul 9;1(1):2.PMID: 19674435 [PubMed]Free PMC ArticleFree textRelated citations

[Pharmacology of Alzheimer's disease: where do we go from here?]

Sellal F, Nieoullon A, Michel G, Michel BF, Lacomblez L, Geerts H, Delini-Stula A, Bentué-Ferrer D, Bordet R, Allain H.

Therapie. 2005 Mar-Apr;60(2):89-107. Review. French. PMID: 15969312 [PubMed - indexed for MEDLINE]Related citations

Alzheimer's disease: clinical trials and drug development.

Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M.

Lancet Neurol. 2010 Jul;9(7):702-16.PMID: 20610346 [PubMed - in process]Related citations

Creativity and dementia: emerging diagnostic and treatment methods for Alzheimer's disease.

Cummings JL, Miller BL, Christensen DD, Cherry D.

CNS Spectr. 2008 Feb;13(2 Suppl 2):1-20; quiz 22.PMID: 18264030 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Disease-modifying trials in Alzheimer's disease: a European task force consensus.

Vellas B, Andrieu S, Sampaio C, Wilcock G; European Task Force group.

Lancet Neurol. 2007 Jan;6(1):56-62. Review.PMID: 17166802 [PubMed - indexed for MEDLINE]Related citations

New developments in mild cognitive impairment and Alzheimer's disease.

Schott JM, Kennedy J, Fox NC.

Curr Opin Neurol. 2006 Dec;19(6):552-8. Review.PMID: 17102693 [PubMed - indexed for MEDLINE]Related citations

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.

Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N.

Health Technol Assess. 2001;5(1):1-137. Review.PMID: 11262420 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Relevance of the evaluation criteria used in clinical trials for Alzheimer's disease.

Truffinet P, Bordet R, Ménard J.

Therapie. 2009 May-Jun;64(3):139-8. Epub 2009 Aug 13. Review. English, French. PMID: 19671425 [PubMed - indexed for MEDLINE]Related citations

Beyond amyloid: the next generation of Alzheimer's disease therapeutics.

Seabrook GR, Ray WJ, Shearman M, Hutton M.

Mol Interv. 2007 Oct;7(5):261-70. Review.PMID: 17932415 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Cognitive enhancement therapy for Alzheimer's disease. The way forward.

Parnetti L, Senin U, Mecocci P.

Drugs. 1997 May;53(5):752-68. Review.PMID: 9129864 [PubMed - indexed for MEDLINE]Related citations

Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.

Lipton SA.

J Alzheimers Dis. 2004 Dec;6(6 Suppl):S61-74.PMID: 15665416 [PubMed - indexed for MEDLINE]Related citations

Treatment strategies in Alzheimer's disease with a focus on early pharmacological interventions.

Marksteiner J, Schmidt R.

Drugs Aging. 2004;21(7):415-26.PMID: 15132710 [PubMed - indexed for MEDLINE]Related citations

Ongoing trials in Alzheimer's disease.

Sramek JJ, Cutler NR.

Expert Opin Investig Drugs. 2000 Apr;9(4):899-915. Review.PMID: 11060718 [PubMed - indexed for MEDLINE]Related citations

Recent developments in Alzheimer's disease therapeutics.

Rafii MS, Aisen PS.

BMC Med. 2009 Feb 19;7:7. Review.PMID: 19228370 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.

Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. Review.PMID: 16409879 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

The NCI All Ireland Cancer Conference.

Johnston PG, Daly PA, Liu E.

Oncologist. 1999;4(4):275-277.PMID: 10545862 [PubMed - as supplied by publisher]Free ArticleRelated citations

Rivastigmine for Alzheimer's disease.

Birks J, Iakovidou V, Tsolaki M.

Cochrane Database Syst Rev. 2000;(2):CD001191. Review. Update in: Cochrane Database Syst Rev. 2000;(4):CD001191. PMID: 10796621 [PubMed - indexed for MEDLINE]Related citations

beta-Amyloid as a molecular therapeutic target in Alzheimer's disease.

Adlard PA, James SA, Bush AI, Masters CL.

Drugs Today (Barc). 2009 Apr;45(4):293-304. Review.PMID: 19499094 [PubMed - indexed for MEDLINE]Related citations

Enrichment of MCI and early Alzheimer's disease treatment trials using neurochemical and imaging candidate biomarkers.

Hampel H, Broich K.

J Nutr Health Aging. 2009 Apr;13(4):373-5.PMID: 19300885 [PubMed - indexed for MEDLINE]Related citations

The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.

Lipton SA.

Curr Alzheimer Res. 2005 Apr;2(2):155-65. Review.PMID: 15974913 [PubMed - indexed for MEDLINE]Related citations